Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zongbin Xu
FBXW4 Acts as a Protector of FOLFOX-Based Chemotherapy in Metastatic Colorectal Cancer Identified by Co-Expression Network Analysis
Frontiers in Genetics
Genetics
Molecular Medicine
Related publications
Prognostic Genes of Triple‑negative Breast Cancer Identified by Weighted Gene Co‑expression Network Analysis
Oncology Letters
Cancer Research
Oncology
Weighted Gene Co-Expression Network Analysis Identified Cancer Cell Proliferation as a Common Phenomenon During Perineural Invasion
OncoTargets and Therapy
Oncology
Pharmacology
Systemic Chemotherapy With FOLFOX in Metastatic Grade 1/2 Neuroendocrine Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
FOLFOX as Second-Line Chemotherapy in Patients With Pretreated Metastatic Pancreatic Cancer From the FIRGEM Study
BMC Cancer
Cancer Research
Oncology
Genetics
Co-Expression Network Analysis Identified CDH11 in Association With Progression and Prognosis in Gastric Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Potential Responders to FOLFOX Therapy for Colorectal Cancer by Random Forests Analysis
British Journal of Cancer
Cancer Research
Oncology
Overexpression of COL3A1 Confers a Poor Prognosis in Human Bladder Cancer Identified by Co-Expression Analysis
Oncotarget
Oncology
A Phase II Study of Modified FOLFOX as First-Line Chemotherapy for Metastatic Gastric Cancer in Elderly Patients With Associated Diseases
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Reply: Oxaliplatin- Or Irinotecan-Based Chemotherapy for Metastatic Colorectal Cancer in the Elderly
British Journal of Cancer
Cancer Research
Oncology